This article provides the risks associated with leads of traditional defibrillators and raises awareness of the subcutaneous ICD and their benefits for hemodialysis patients” Vachharajani et al (2017).
Defibrillation can be successfully provided by the subcutaneous implantable cardioverter defibrillator (ICD) without the leads. In contrast, traditional ICDs require leads that can cause central venous stenosis, lead-induced endocarditis, and carry the risk of tricuspid regurgitation by valve adhesion, perforation, coaptation interference, or entanglement.
ReTweet if useful… The role of subcutaneous defibrillators for dialysis patients https://ctt.ec/scdm3+ @ivteam #ivteam
Central venous stenosis, infection, and tricuspid regurgitation are all critically important considerations in hemodialysis patients. Recent reports are supporting the use of subcutaneous ICDs in renal patients maintained on long-term hemodialysis. This article provides the risks associated with leads of traditional defibrillators and raises awareness of the subcutaneous ICD and their benefits for hemodialysis patients.
Vachharajani, T.J., Salman, L., Costanzo, E.J., Mehandru, S.K., Patel, M., Calderon, D.M., Mathew, R.O., Sidhu, M.S. and Asif, A. (2017) Subcutaneous defibrillators for dialysis patients. Hemodialysis International. June 23rd. [Epub ahead of print].
Thank you to our partners for supporting IVTEAM